The Therapeutic Effects of Sevelamer on Blood Sugar, HbA1c, Lipid Profile, and hs-CRP in Patients with Diabetic Nephropathy

• Principais autores: Sosan Mohammadi Kebar (Autor), Afshan Shargi (Autor), Bahman Bashardoust (Autor), Manouchehr Iranparvar (Autor), Hossein Fekri (Autor), Afshin Habibzadeh (Autor)
• Formato: Livro
• Publicado em: Society of Diabetic Nephropathy Prevention, 2018-04-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Background: Diabetic nephropathy (DN) is one of the major complications of diabetes. Hyperglycemia, inflammation and oxidative stress as well as advanced glycation end products (AGEs) are reported as the risk factors for DN. Sevelamer has shown promising results in reducing inflammation and even HbA...